Articles récents
- UZEDY®: Q3 U.S. Net Sales Reach $85M, Up 96% Year-on-Year; 2026 Revenue Outlook Raised to $290-310M
- Medincell Announces New Publication Date for Its Half-Year Financial Result (April 1st – September 30, 2026)
- Medincell Brings Total Non-Dilutive Financing Secured Since July 2026 to €41.8 Million with an Additional €13.8 Million Loan
- Investor Webcast – WELTRUZA™ FDA Approval
- General Meeting 2026 (French)
Commentaires récents
No comments to show.
